J Thome, U Knopf. Show Affiliations »
Abstract
Entities: Disease Gene
Mesh: See more » AdultAntipsychotic Agents/therapeutic useFemaleHepatitis C/drug therapyHumansHypnotics and Sedatives/therapeutic useInterferon alpha-2Interferon-alpha/administration & dosageInterferon-alpha/adverse effectsPolyethylene Glycols/administration & dosagePolyethylene Glycols/adverse effectsPsychotic Disorders/drug therapyPsychotic Disorders/etiologyRecombinant ProteinsTreatment Outcome
Substances: See more » Antipsychotic AgentsHypnotics and SedativesInterferon alpha-2Interferon-alphaRecombinant ProteinsPolyethylene Glycolspeginterferon alfa-2a
Year: 2003 PMID: 12763304 DOI: 10.1016/s0924-9338(03)00032-4
Source DB: PubMed Journal: Eur Psychiatry ISSN: 0924-9338 Impact factor: 5.361